unknown
Stage
1
Investors
About
Aikium develops an AI-driven platform combining deep learning and large-scale wet lab experimentation to design and screen protein therapeutics that target challenging disease-associated proteins missed by traditional drug discovery methods.
Explore Aikium's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.